Literature DB >> 15084180

MELD and other factors associated with survival after liver transplantation.

K V Narayanan Menon1, Scott L Nyberg, William S Harmsen, Nelson F DeSouza, Charles B Rosen, Ruud A F Krom, Russell H Wiesner.   

Abstract

Allocation of cadaveric livers for transplantation in the United States is now based on the severity of illness as determined by the model for end-stage liver disease (MELD) score, a function of bilirubin, creatinine and international normalized ratio (INR). The aim of our study was to determine the association of various pre-transplant risk factors, including the MELD score, on patient survival after orthotopic liver transplantation (OLT). The medical records of 499 consecutive patients (233 female, 266 males, mean age 50.9 +/- 10.6 years) undergoing cadaveric OLT at our institution between June 1990 and February 1998 were reviewed. In the 407 patients alive at the latest contact, follow-up was 4.7 years, with a minimum of 20 months (maximum of 9.4 years). Variables considered for analysis included MELD score, age, pre-transplant renal dysfunction requiring dialysis, Child-Pugh classification, underlying liver disease, diabetes mellitus, and heart disease (ischemic/valvular/other). There were 92 deaths during follow-up. In univariate analysis, the MELD score, renal failure requiring hemodialysis pre-OLT, age > 42 years, and underlying etiology of liver disease were significantly associated with death during long-term follow-up. In multivariate models, age, underlying etiology of liver disease and renal failure requiring hemodialysis were independent predictors of death after OLT.

Entities:  

Mesh:

Year:  2004        PMID: 15084180     DOI: 10.1111/j.1600-6143.2004.00433.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  31 in total

1.  MELD score does not discriminate against patients with hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Kia Saeian
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

2.  The impact of MELD allocation on simultaneous liver-kidney transplantation.

Authors:  Julie A Thompson; John R Lake
Journal:  Curr Gastroenterol Rep       Date:  2009-02

3.  Pre- and Peri-Operative Factors Associated with Chronic Critical Illness in Liver Transplant Recipients.

Authors:  Nicholas E Ingraham; Christopher J Tignanelli; Jeremiah Menk; Jeffrey G Chipman
Journal:  Surg Infect (Larchmt)       Date:  2019-10-16       Impact factor: 2.150

4.  Pretransplant diabetes mellitus predicts worse outcomes of liver transplantation: evidence from meta-analysis.

Authors:  P Li; H Fan; Q He
Journal:  J Endocrinol Invest       Date:  2017-06-30       Impact factor: 4.256

5.  Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era.

Authors:  Maricar F Malinis; Shu Chen; Heather G Allore; Vincent J Quagliarello
Journal:  Ann Transplant       Date:  2014-09-26       Impact factor: 1.530

6.  Application of the BAR score as a predictor of short- and long-term survival in liver transplantation patients.

Authors:  Ivan Dias de Campos Junior; Raquel Silveira Bello Stucchi; Elisabete Yoko Udo; Ilka de Fátima Santana Ferreira Boin
Journal:  Hepatol Int       Date:  2014-08-09       Impact factor: 6.047

7.  Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era.

Authors:  Reena J Salgia; Nathan P Goodrich; Heather Simpson; Robert M Merion; Pratima Sharma
Journal:  Dig Dis Sci       Date:  2014-02-21       Impact factor: 3.199

8.  Aorto-hepatic bypass in liver transplantation in the MELD-era: outcomes after supraceliac and infrarenal bypasses.

Authors:  Richard Hummel; Sabrina Irmscher; Christina Schleicher; Norbert Senninger; Jens G Brockmann; Heiner H Wolters
Journal:  Surg Today       Date:  2013-03-05       Impact factor: 2.549

9.  Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone.

Authors:  Pratima Sharma; Nathan P Goodrich; Min Zhang; Mary K Guidinger; Douglas E Schaubel; Robert M Merion
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

10.  Effect of pretransplant serum creatinine on the survival benefit of liver transplantation.

Authors:  Pratima Sharma; Douglas E Schaubel; Mary K Guidinger; Robert M Merion
Journal:  Liver Transpl       Date:  2009-12       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.